Key result
Guidelines recommend catheter ablation in high-risk SVT and WPW to prevent sudden cardiac death.
Why the study?
Does catheter ablation prevent sudden cardiac death in patients with supraventricular tachycardia at high risk?
Does catheter ablation prevent sudden cardiac death in patients with supraventricular tachycardia at high risk?
This review consolidates current guideline recommendations for the management and catheter ablation of SVT in patients at high risk for sudden cardiac death.
Answers are grounded in this paper and cite their sources.
Reinforces guideline-directed ablation for high-risk SVT; leaves open prospective RCTs to confirm SCD prevention.
Patients with Wolff-Parkinson-White syndrome (WPW), neonates, and patients with major structural cardiac pathology who suffer from supraventricular tachycardia are at higher risk of sudden cardiac death. The review article accumulates evidence-based knowledge provided in the recent guidelines and expert consensus on the prevention of sudden cardiac death in adults and children with different SVT types. The review provides current data on the risk of sudden cardiac death in patients with supraventricular tachycardia, possible pathogenetic patterns of sudden cardiac death in this patient population, current guidelines on catheter ablation for supraventricular tachycardia to prevent sudden cardiac death in adults and children.
No takes yet. Share an insight, caveat, or question.
Мамчур et al. (2018) conducted a review in Supraventricular tachycardia at high risk of sudden cardiac death (WPW, neonates, structural heart disease). Catheter ablation and guideline-directed management was evaluated on Prevention of sudden cardiac death. Current guidelines recommend catheter ablation for supraventricular tachycardia to prevent sudden cardiac death in high-risk adults and children, including those with WPW syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: